Jean‐Marie Rakic

2.4k total citations
42 papers, 1.8k citations indexed

About

Jean‐Marie Rakic is a scholar working on Ophthalmology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jean‐Marie Rakic has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Ophthalmology, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Jean‐Marie Rakic's work include Retinal Diseases and Treatments (15 papers), Protease and Inhibitor Mechanisms (9 papers) and Glaucoma and retinal disorders (8 papers). Jean‐Marie Rakic is often cited by papers focused on Retinal Diseases and Treatments (15 papers), Protease and Inhibitor Mechanisms (9 papers) and Glaucoma and retinal disorders (8 papers). Jean‐Marie Rakic collaborates with scholars based in Belgium, United Kingdom and United States. Jean‐Marie Rakic's co-authors include Vincent Lambert, Agnès Noël, Carine Munaut, Gijs F.J.M. Vrensen, Jean‐Michel Foidart, Maud Jost, Ingrid Struman, Maria-Luz Alvarez-Gonzalez, Laetitia Devy and Jean Michel Foidart and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Jean‐Marie Rakic

40 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean‐Marie Rakic Belgium 18 1.0k 884 552 498 135 42 1.8k
Robert N. Mames United States 18 803 0.8× 998 1.1× 507 0.9× 208 0.4× 104 0.8× 39 1.9k
Lea Scheppke United States 10 283 0.3× 976 1.1× 155 0.3× 474 1.0× 39 0.3× 13 1.5k
Tetsuo Hida Japan 26 1.7k 1.7× 736 0.8× 1.3k 2.3× 81 0.2× 48 0.4× 79 2.4k
Salvatore Grisanti Germany 31 2.6k 2.5× 884 1.0× 1.9k 3.4× 101 0.2× 36 0.3× 192 3.3k
EunDuck P. Kay United States 29 531 0.5× 806 0.9× 1.3k 2.4× 131 0.3× 21 0.2× 57 2.1k
Jaeryung Kim South Korea 19 575 0.6× 491 0.6× 465 0.8× 102 0.2× 15 0.1× 38 1.4k
Matthew R. Ritter United States 15 234 0.2× 561 0.6× 185 0.3× 79 0.2× 58 0.4× 19 1.1k
Alexandre Moulin Switzerland 23 1.6k 1.5× 700 0.8× 705 1.3× 116 0.2× 23 0.2× 89 2.3k
Eiichi Sekiyama Japan 12 836 0.8× 670 0.8× 747 1.4× 67 0.1× 21 0.2× 14 1.5k
Jian Qi China 12 125 0.1× 505 0.6× 113 0.2× 388 0.8× 86 0.6× 30 1.1k

Countries citing papers authored by Jean‐Marie Rakic

Since Specialization
Citations

This map shows the geographic impact of Jean‐Marie Rakic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Marie Rakic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Marie Rakic more than expected).

Fields of papers citing papers by Jean‐Marie Rakic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean‐Marie Rakic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Marie Rakic. The network helps show where Jean‐Marie Rakic may publish in the future.

Co-authorship network of co-authors of Jean‐Marie Rakic

This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Marie Rakic. A scholar is included among the top collaborators of Jean‐Marie Rakic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Marie Rakic. Jean‐Marie Rakic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rakic, Jean‐Marie, et al.. (2024). Utility of ganglion cells for the evaluation of anterior visual pathway pathology: a review. Acta Neurologica Belgica. 124(4). 1113–1123.
2.
3.
Georges, Anouk, Michiko Mandai, Latifa Karim, et al.. (2023). Comparing the transcriptome of developing native and iPSC-derived mouse retinae by single cell RNA sequencing. Scientific Reports. 13(1). 1223–1223. 3 indexed citations
4.
Rampat, Radhika, et al.. (2021). Drones’ side effect: facial and ocular trauma caused by an aerial drone. BMJ Case Reports. 14(3). e238316–e238316. 2 indexed citations
5.
Lambert, Vincent, Sylvain Hansen, Julie Lecomte, et al.. (2020). Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics. Journal of Molecular Medicine. 98(12). 1737–1751. 18 indexed citations
6.
Rakic, Jean‐Marie, et al.. (2018). [Painful Horner's syndrome revealing carotid artery dissection : about four cases].. PubMed. 73(7-8). 428–432. 1 indexed citations
7.
Lambert, Vincent, Justine Leenders, Bernadette Govaerts, et al.. (2018). NMR-based Metabolomics for New Target Discovery and Personalized Medicine: Application to Age-Related Macular Degeneration (AMD).. Open Repository and Bibliography (University of Liège). 1 indexed citations
8.
Tullio, Pascal De, Vincent Lambert, Sylvain Hansen, et al.. (2016). From Metabolomics to Identification of a new therapeutic approach for Age-Related Macular Degeneration (AMD). Open Repository and Bibliography (University of Liège). 1 indexed citations
9.
Lecomte, Julie, B. Detry, Silvia Blacher, et al.. (2010). Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cellular and Molecular Life Sciences. 68(4). 677–686. 30 indexed citations
10.
Dubail, Johanne, Frédéric Kesteloot, Claude Deroanne, et al.. (2010). ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cellular and Molecular Life Sciences. 67(24). 4213–4232. 62 indexed citations
11.
Blaise, Pierre, et al.. (2010). Retinitis pigmentosa and bronchiectasis: a case report on a rare association suggestive of a common underlying primary ciliary dyskinesia (PCD).. PubMed. 9–14. 4 indexed citations
12.
Rakic, Jean‐Marie, et al.. (2009). [VEGF inhibitors in ophthalmology].. PubMed. 64(5-6). 323–6. 2 indexed citations
13.
Blaise, Pierre, et al.. (2007). Wegener's granulomatosis and posterior ischemic optic neuropathy: Atypical associated conditions. European Journal of Internal Medicine. 18(4). 326–327. 10 indexed citations
14.
Kuiper, Esther J., Peggy Roestenberg, Christoph Ehlken, et al.. (2007). Angiogenesis Is Not Impaired in Connective Tissue Growth Factor (CTGF) Knock-out Mice. Journal of Histochemistry & Cytochemistry. 55(11). 1139–1147. 35 indexed citations
15.
Blaise, Pierre, et al.. (2007). Atrophie papillaire bilatérale chez un patient héroïnomane. Journal Français d Ophtalmologie. 30(9). 945.e1–945.e4. 2 indexed citations
16.
Blaise, Pierre, et al.. (2006). OPTICAL COHERENCE TOMOGRAPHY IN THE DIAGNOSIS OF PREMACULAR HEMORRHAGE. Retina. 26(2). 232–234. 4 indexed citations
17.
Rakic, Jean‐Marie, Vincent Lambert, Carine Munaut, et al.. (2003). Mice without uPA, tPA, or Plasminogen Genes Are Resistant to Experimental Choroidal Neovascularization. Investigative Ophthalmology & Visual Science. 44(4). 1732–1732. 46 indexed citations
18.
Rakic, Jean‐Marie, Catherine Maillard, Maud Jost, et al.. (2003). Role of plasminogen activator-plasmin system in tumor angiogenesis. Cellular and Molecular Life Sciences. 60(3). 463–473. 104 indexed citations
19.
Lambert, Vincent, Carine Munaut, Maud Jost, et al.. (2002). Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization. American Journal Of Pathology. 161(4). 1247–1253. 101 indexed citations
20.
Lambert, Vincent, Carine Munaut, Agnès Noël, et al.. (2001). Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. The FASEB Journal. 15(6). 1021–1027. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert N. Mames Breakdown of academic impact, for papers by Lea Scheppke Breakdown of academic impact, for papers by Tetsuo Hida Breakdown of academic impact, for papers by Salvatore Grisanti Breakdown of academic impact, for papers by EunDuck P. Kay Breakdown of academic impact, for papers by Jaeryung Kim Breakdown of academic impact, for papers by Matthew R. Ritter Breakdown of academic impact, for papers by Alexandre Moulin Breakdown of academic impact, for papers by Eiichi Sekiyama Breakdown of academic impact, for papers by Jian Qi
Rankless by CCL
2026